Evidence reviewed: 8 November 2026. Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. It can produce a painless sore, a rash or no noticeable symptoms, and untreated infection can damage the nervous system, eyes, hearing, heart and other organs. Syphilis is curable with appropriately selected antibiotics, but the medication and duration depend on the stage and whether the nervous system, eyes or ears are involved. Penicillin G is the preferred treatment; it is also the only proven treatment to prevent congenital syphilis during pregnancy [1-4].
How does syphilis spread?
Syphilis spreads mainly through direct contact with an infectious syphilitic sore or lesion during vaginal, anal or oral sex. A pregnant person can transmit infection to the fetus, potentially causing miscarriage, stillbirth, neonatal disease or severe long-term complications. Rare transmission by other routes is possible, but casual everyday contact such as sharing a toilet seat or eating utensils does not spread syphilis [1].
Infection may not produce obvious symptoms. A sore may be painless, hidden in the mouth, rectum or genital tract, or heal without treatment. Healing of a lesion does not necessarily mean the infection is gone. Anyone with a known exposure, a compatible symptom or increased STI risk should seek testing.
The stages of syphilis
Primary syphilis
The classic sign is a chancre, typically a firm, round, painless ulcer at the site of infection. Multiple or atypical painful lesions can occur. Nearby lymph nodes may enlarge. The sore can disappear spontaneously after several weeks, even though infection persists without appropriate treatment. Because the lesion can be internal, some people do not know they were infected [1].
Secondary syphilis
Symptoms can include a generalized rash, sometimes involving the palms of the hands and soles of the feet, along with fever, sore throat, swollen lymph nodes, fatigue, patchy hair loss or mucosal lesions. The rash may not itch and can be subtle. These features can overlap with many other conditions, so examination and laboratory testing are essential. Secondary symptoms may resolve and recur without eradicating infection [1].
Latent syphilis
Latent syphilis means blood tests support infection but there are no clinical signs or symptoms of primary or secondary disease. It is classified as early latent when infection was acquired within the previous year based on accepted criteria, or late latent/unknown duration when evidence of acquisition in the past year is lacking. A high RPR titer alone does not prove early latent infection [2]. Accurate staging matters because treatment schedules differ.
Tertiary syphilis and neurologic, ocular or otic disease
Years after untreated infection, some people develop gummatous or cardiovascular complications. Neurosyphilis, ocular syphilis and otosyphilis are not simply a separate late stage: they may occur at any time during infection. New vision changes, eye pain, hearing loss, tinnitus, severe headache, cranial nerve symptoms, altered mental status or focal neurological deficits in a person with possible syphilis warrant prompt medical assessment; vision or hearing symptoms can require emergency specialist treatment [3].
How is syphilis diagnosed?
Diagnosis normally combines the patient’s history and examination with two types of serological testing:
- Nontreponemal tests, such as RPR or VDRL, can be reported as quantitative titers (for example 1:8 or 1:32). Titers are useful for assessing response to treatment, but are not interpreted in isolation.
- Treponemal tests, such as TP-PA and many laboratory immunoassays, detect antibodies associated with T. pallidum. They often remain positive for life even after successful treatment and generally cannot distinguish a new from an old treated infection by themselves.
Laboratories may use a traditional sequence (nontreponemal test followed by treponemal confirmation) or a reverse-sequence algorithm. Discrepant results require appropriate follow-up testing and clinical interpretation. A recent infection may initially test negative; repeat testing can be required when exposure or lesions are strongly suggestive [1].
Testing and evaluation for HIV and other STIs should be considered at diagnosis. Lumbar puncture and cerebrospinal fluid analysis are not routinely required for uncomplicated early syphilis without neurologic findings. CSF examination is guided by symptoms and specialist evaluation; isolated ocular or otic signs may not always require CSF sampling before treatment [3].
Evidence-based treatment: why the stage matters
Clinicians select the correct penicillin G formulation, route and duration based on stage, pregnancy and specialist findings. Do not substitute combined benzathine-procaine products or short-acting penicillin for the long-acting benzathine formulation used for uncomplicated early or latent syphilis [1].
| Diagnosis in adults | CDC recommended first-line regimen |
|---|---|
| Primary or secondary syphilis | Benzathine penicillin G 2.4 million units IM once [4] |
| Early latent syphilis | Benzathine penicillin G 2.4 million units IM once [2] |
| Late latent syphilis or latent syphilis of unknown duration | Benzathine penicillin G 2.4 million units IM weekly for 3 weeks (7.2 million units total) [2] |
| Neurosyphilis, ocular syphilis or otosyphilis | Aqueous crystalline penicillin G 18–24 million units/day IV, given as 3–4 million units every 4 hours or continuous infusion, for 10–14 days, under specialist care [3] |
These are guideline regimens, not instructions for self-treatment. Congenital syphilis, some manifestations of tertiary disease, pregnancy and complex allergies require additional individualized assessment. An intramuscular benzathine penicillin regimen is not adequate treatment for neurosyphilis by itself [3].
What if someone has a penicillin allergy?
For nonpregnant patients with early syphilis who cannot receive penicillin, CDC guidance recognizes alternatives such as doxycycline 100 mg by mouth twice daily for 14 days, but supporting evidence is more limited and close clinical and serologic follow-up is essential. For selected late latent infections, alternative treatment may require a longer course and careful monitoring [2,4]. Allergy histories should be reviewed because many reported ‘penicillin allergies’ are not confirmed.
Do not use azithromycin for syphilis. Resistance and treatment failures make it unreliable; the original version of this article listed an azithromycin schedule that is not recommended [4]. Ceftriaxone may be an alternative in selected cases of neurosyphilis, but the regimen requires specialist input and should not be assumed equivalent in every situation [3].
Syphilis during pregnancy: treatment cannot wait
Syphilis screening is a vital part of prenatal care. Penicillin G is the only proven therapy for fetal infection and prevention of congenital syphilis. Pregnant patients should receive a penicillin regimen appropriate for their stage, with any additional doses or imaging decisions individualized by the prenatal specialist. Anyone pregnant with a documented penicillin allergy should be evaluated and, when indicated, desensitized and treated with penicillin rather than relying on doxycycline, azithromycin or unproven substitutes [5].
Missed weekly doses during a required multiweek pregnancy regimen may mean the entire course needs repeating. Do not postpone treatment while awaiting fetal ultrasonography, and ensure appropriate prenatal follow-up and partner assessment [5].
What is the Jarisch–Herxheimer reaction?
During the first 24 hours after starting treatment, some people—particularly those with early syphilis—develop fever, headache, muscle aches and transient worsening of existing symptoms. This is called the Jarisch–Herxheimer reaction and is usually a self-limited response to treatment rather than a penicillin allergy. Discuss expected symptoms and appropriate supportive care with the treating clinician. However, hives, facial swelling, wheezing or breathing difficulty after an injection may be allergic emergency symptoms and require immediate medical attention [1,5].
Follow-up: how do doctors know whether treatment worked?
Quantitative RPR or VDRL titers, preferably using the same test method and laboratory, help track response. A clinically significant change is generally fourfold, meaning a two-dilution difference (for example, 1:32 to 1:8). For primary or secondary syphilis, CDC recommends clinical and serologic assessment at 6 and 12 months, with individual adjustments. Late latent infection generally needs serologic checks at 6, 12 and 24 months [2,4]. Pregnancy and HIV infection can require different schedules.
Not everyone becomes RPR-negative after treatment, and some correctly treated patients have persistent low titers. An inadequate decline does not always prove failure; interpret it in the context of baseline titer, time since treatment, stage, symptoms and risk of reinfection. Conversely, a sustained fourfold rise suggests reinfection or treatment failure and merits reassessment [2,4].
Partners, prevention and reinfection
Sex partners should be notified confidentially and assessed under local public-health procedures. CDC advises presumptive treatment for partners with certain recent exposures to primary, secondary or early latent syphilis even if tests are initially negative [1]. Avoid sex until a clinician confirms it is safe after treatment and lesions have healed, and follow advice about partner evaluation. Condoms reduce but do not eliminate risk when infectious lesions are outside the covered area. A prior syphilis infection does not produce lasting immunity.
Frequently asked questions
Can syphilis be cured with one injection?
Some stages—primary, secondary and early latent syphilis—are usually treated with one recommended benzathine penicillin G dose. Late latent infection needs three weekly doses and neurosyphilis needs a different IV treatment [2-4].
Can a blood test remain positive after successful treatment?
Yes. Treponemal tests often stay positive. Follow quantitative RPR or VDRL trends rather than expecting every test to become negative [1].
Is syphilis dangerous in pregnancy?
Yes. Untreated infection can infect the fetus. Timely screening and stage-appropriate penicillin treatment are essential [5].
Can syphilis affect vision or hearing?
Yes, sometimes at an early stage. New visual or hearing changes require prompt professional evaluation [3].
Does doxycycline work for everyone with syphilis?
No. It is an alternative for selected nonpregnant patients with certain stages and requires close follow-up. It is not a substitute for recommended penicillin treatment during pregnancy or routine neurosyphilis management [3-5].
Key takeaways
Test correctly, stage accurately, treat with the appropriate penicillin formulation and complete follow-up. Syphilis can be silent, can recur after reinfection, and can affect the fetus, eyes, ears or nervous system. Avoid unsupported alternative regimens such as azithromycin.
References
- Centers for Disease Control and Prevention. Syphilis: STI treatment guidelines. Reviewed Oct 2024; accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. Latent syphilis: STI treatment guidelines. Accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. Neurosyphilis, ocular syphilis and otosyphilis: STI treatment guidelines. Accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. Primary and secondary syphilis: STI treatment guidelines. Accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. Syphilis during pregnancy: STI treatment guidelines. Accessed 8 Nov 2026.
Medical disclaimer: This article is for education, not self-prescribing. Syphilis requires clinical diagnosis, stage-specific treatment, partner care and follow-up. Local guidelines, medication availability and specialist recommendations may differ.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.